





Silencing of Heat Shock Protein 
70 Expression Enhances 
Radiotherapy Efficacy and 
Inhibits Cell Invasion in 
Endometrial Cancer Cell Line
Aim To investigate the role of heat shock proteins 70 
(HSP70) in radiosensitivity and invasiveness of endometrial 
cancer in vitro.
Methods HSP70 expression was silenced in relatively ra-
dioresistant, well-differentiated human endometrial can-
cer cell line ISK, using small interference RNA method, or by 
HSP70 overexpression after transfecting a HSP70-express-
ing vector. The effect of HSP70 on ISK cell line response 
to irradiation was evaluated. The surviving fraction was 
measured using colony-formation assay. Apoptosis was 
detected by flow cytometry and HSP70 expression was 
determined by quantitative real-time polymerase chain re-
action, western-blot, and/or immuocytochemistry. Cell in-
vasiveness was measured using transwell invasion assay.
Results HSP70 silencing caused a significant increase in 
irradiation-induced cell killing in comparison with con-
trol cells, with an enhancement factor of 1.27, and in the 
percentage of apoptotic cells (14.22% vs 6.74%, P = 0.021). 
After 4 Gy irradiation, mean ± standard deviation survival 
fraction in ISK cells was reduced to 0.32 ± 0.04 in compari-
son with control values but in ISK/siRNA-HSP70 cells the 
survival fraction was higher and amounted to 0.51 ± 0.08 
(P = 0.026). Silencing HSP70 significantly inhibited cell inva-
sion before and after irradiation (106 ± 19 vs 219 ± 18 and 
119 ± 16 vs 256 ± 31, P = 0.007). On the contrary, ectopic 
overexpression of HSP70 attenuated irradiation-induced 
apoptosis (7.15% vs 4.08%, P = 0.043) and induced more 
ISK/HSP70 cells invaded through the filters than mock-in-
fected cells before and after irradiation (274 ± 21 vs 194 ± 16 
before irradiation, and 298 ± 24 vs 227 ± 19 after irradiation, 
respectively, P = 0.032).
Conclusion Disruption of HSP70-induced cytoprotec-
tion during irradiation enhances therapeutic effect of irra-
diation, which makes HSP70 a promising target in the re-
search of endometrial cancer.
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Endometrial cancer is one of the most common gyneco-
logic malignancies worldwide, with radiation therapy as a 
very important treatment option (1). However, the efficacy 
of radiation therapy is often limited by radioresistance, ie, 
diminished susceptibility of the irradiated cells to under-
go apoptosis. In our previous studies, we found that hu-
man heat shock protein 70 (HSP70) was significantly over-
expressed in radioresistant endometrial cancer cells line 
ISK compared with relatively radiosensitive cells after irra-
diation (2). This suggested that irradiation-induced HSP70 
content may play an important role in the development of 
radioresistance.
The HSP70 family contains at least 8 homologous chaper-
one proteins (3). Endoplasmatic reticulum and mitochondria 
have their specific HSP70 proteins, whereas the remaining 6 
family members reside mainly in the cytosol and nucleus. 
HSP70B’ is the major human isoform in the HSP70 family that 
is strictly stress-inducible and therefore available to function 
only in stressed cells (4). Phylogenetic analysis indicated that 
the HSP70B’ protein sequence was most closely related to 
another major inducible human HSP70 – HSP72. HSP70B’ 
and HSP72 together play a role in cell survival after proteo-
toxic stress. Inducible HSP70 are up-regulated in the major-
ity of human tumors and are believed to have an important 
role in cell proliferation, tumor growth, and cancer invasive-
ness (5-8). Overexpression of HSP70 in human tumors is as-
sociated with poor prognosis and poor response to radia-
tion therapy (9,10). Some in vitro studies suggested that the 
viability of cells pretreated with exogenous HSP70 before ra-
diation was indeed protected and that transfection of cells 
with a siRNA designed to interfere with HSP70 synthesis in-
creased the irradiation-induced apoptosis (11,12). Despite 
this, the role of HSP70 in endometrial cancer is largely un-
known. Understanding of HSP70s function in endometrial 
cancer may provide clues to the development of radiore-
sistance and offer alternatives for clinical treatment. Mean-
while, it is well known that metastasis is highly depend-
ent on tumor cell invasion. Previous studies reported that 
overexpression of HSP70 induced the expression of matrix 
metallopeptidase 9 (MMP-9) and thereby improved the cell 
invasiveness (13). In the present study, we investigated the 
role of HSP70 in radiosensitivity and invasiveness of a well 
defined endometrial cancer cell in vitro.
MaTeRials anD MeThoDs
Cell culture
Three human endometrial cancer cell lines were ob-
tained from the Type Culture Collection of Chinese 
Academy of Sciences (Beijing, China): ISK (well differenti-
ated, relatively radioresistant), RL95-2 (moderately differ-
entiated, radiosensitive), and KLE (poorly differentiated, ra-
diosensitive). RL95-2 and KLE cells were cultured in DMEM 
(Gibco BRL, Gaithersburg, MD, USA), supplemented with 
100 U/mL penicillin/streptomycin. ISK cells, stably trans-
fected with pcDNA3.1, pcDNA3-HSP70, and pcDNA3-siH-
SP70, were maintained in DMEM in the presence of G-418 
(400 µg/mL). All media were supplemented with 10% fetal 
bovine serum (FBS) and 2 mmol/L glutamine. The cultures 
were incubated at 37°C in a humidified 5% CO2 incubator.
irradiation
Cells were cultured in 60-mm dishes until 70% to 80% con-
fluent and then exposed to x-rays from a VARIAN clinical 
2100C/D linear accelerator (VARIAN, Palo Alto, CA, USA) at 
a dose rate of 2.0 Gy/min.
Clonogenic cell survival assay
The surviving fraction was measured using a standard col-
ony-formation assay. Cells were transfected as above with 
vehicle, siHSP70, and pcDNA3-HSP70. Seventy-two hours 
after transfection, cells were trypsinized, counted, and ap-
proximately 200 cells were plated in six-well plates and al-
lowed to attach for 6 hours. After 6 hours, cells were irradi-
ated and incubated for 12 days. Colonies were stained with 
crystal violet and those with ≥50 cells were counted. Five 
replicate dishes were counted for each treatment.
Creation of isK/siRna-hsP70 cells
A 21-nucleotide DNA sequence 5’-CACAAGAAGGACAT-
CAGCCTT-3’ targeting HSP70 was designed by Kangchen 
(Shanghai, China). The 21-nucleotide oligonucleotide 5’-
CTTAGGCTGTTACATCTCTCC-3’, which had no significant 
homology to any known human mRNA, was used as a neg-
ative control. The sequence of each insert was confirmed 
by automated sequencing. Cells were transfected with 
HSP70 siRNA (ISK/siRNA) or control siRNA (ISK/control) us-
ing Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) fol-
lowing the manufacturer's instructions. Stable integrants 
were selected by G-418 (400 µg/mL) starting 72 hours af-
ter transfection. After 2 weeks, one pool was isolated and 
subjected to further cloning procedures by the limiting di-
lution method. After 8 weeks, 2 clones with a >95% reduc-
tion in HSP70 protein levels compared with control were 
isolated. Cells were frequently tested for the expression of 
HSP70 by Western blot analysis. One stable clone express-
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ing reduced levels of HSP70 protein was repeatedly select-
ed and maintained in 400 µg/mL G418 selection medium. 
The G-418 selective pressure was removed 24 hours before 
experimental procedures.
Creation of isK/hsP70 cells
The HSP70 expression vector pcDNA3-HSP70 containing 
the cDNA for full-length human HSP70 was designed by 
Kangchen (Kangchen, Shanghai, China). Cells grown on 
60-mm dishes were transfected with pcDNA3-HSP70 (ISK/
HSP70) or pcDNA3.1 (ISK/Neo) using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s instructions. 
Clones resistant to G418 (400 µg/mL) were selected and then 
subcloned by limiting dilution. Stable clones were formed 
and maintained in 400 μg/mL G418 selection medium.
Quantitative real-time polymerase chain reaction (RT-
PCR) data analysis
Total RNA was harvested from cells before and 1 hour after 
4 Gy radiation exposure using TRIzol (Invitrogen), concen-
trated using isopropyl alcohol precipitation, and further 
purified using RNeasy Mini kit (Qiagen, Valencia, CA, USA) 
according to the manufacturer’s protocols. The quantity 
and quality of the purified RNA were assessed by 260/280 
optical density (OD) measurements on a spectrophotome-
ter and the integrity was determined by formaldehyde de-
natured gel electrophoresis.
To determine the level of HSP70 mRNA, quantitative RT-
PCR was performed on an ABI Prism 7000 Sequence De-
tection System using SYBR Green RT-PCR Kit (Applied 
Biosystems, Foster City, CA, USA). PCR reaction was per-
formed using 20 µL of total reaction mixture volume, 
containing 1 µL of cDNA reaction products, 10 µL SYBR 
Green PCR Master Mix, and 500 nM of forward and re-
verse primers. The gene-specific primers were as follows: 
HSP70, 5’-TGTTCCGTTTCCAGCCCCCAA-3’ (sense) and 5’-
GGGCTTGTCTCCGTCGTTGAT-3’ (antisense); and GAPDH, 5’-
GGGAGCCAAAAGGGTCATCATCTC-3’(sense) and 5’-CCAT-
GCCAGTGAGCTTCCCGTTC-3’ (antisense). The protocol of 
RT-PCR was as follows: initiation with a 10 minutes of de-
naturation at 95°C, followed by 40 cycles of amplification 
at 95°C (10 seconds) for denaturation, 10 seconds of hy-
bridization at 58°C for HSP70 or 57°C for GAPDH, and 20 
seconds of extension at 72°C. The RT-PCR amplification 
product was analyzed by melting curve analysis and 1.2% 
agarose gel electrophoresis, and the fold-change was de-
termined based on average cycle threshold (Ct) values for 
triplicates. Gene expression levels were calculated and pre-
sented with 2-∆∆Ct values (14).
Protein extraction and Western blotting
Seventy-five percent confluent cells were irradiated with 4 
Gy x-ray. After 1 hour, cells were harvested and lysed with 
cold RIPA buffer. Total cell lysates were clarified by centrifu-
gation (14 000 rpm, 20 minutes) at 4°C. Total protein con-
centration was determined by BCA Protein Assay kit (Pierce, 
Rockford, IL, USA). Twenty micrograms of each soluble pro-
tein sample was separated by 15% SDS-polyacrylamide gel 
electrophoresis and transferred to a nitrocellulose mem-
brane. After blocking with 5% TBST-milk (20 mmol/L Tris-
HCl, 137 mM NaCl, 1.5% nonfat dry milk, and 0.1% Tween20, 
pH 7.6), membranes were incubated with rabbit polyclonal 
anti-HSP70 (1:2000) and anti-β-actin antibodies (sc-33575, 
Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight 
at 4°C. Following this, they were washed and incubated 
with horseradish peroxidase-conjugated anti-rabbit IgG an-
tibody, incubated in SuperSignal® West Pico Chemilumines-
cent Substrate (Pierce), exposed to CL-Xposure Film (Pierce), 
and developed using an All-Pro 100 Plus automated x-ray 
film processor (All-Pro Imaging Corporation, Hicksville, NY, 
USA). The resultant bands were quantified using AlphaEase-
FC software (AlphaInnotech, San Leandro, CA, USA).
apoptosis analysis
The Annexin V-FITC kit (BD Biosciences, San Diego, CA, USA) 
was used to identify apoptotic and viable cells, with slight 
modifications of manufacturer’s instructions. After exposed 
to 4 Gy radiation, cells were harvested by trypsinization (In-
vitrogen), washed with cold PBS, and resuspended in 100 
µL of binding buffer. A total of 5 µL of Annexin V-FITC and 
10 µL of propidium iodide (PI) were added and the mixture 
was incubated for 30 minutes in the dark. Finally, 400 µL of 
binding buffer was added to the cells, the mixture was ana-
lyzed with a flow cytometer, using FITC signal detector and 
PI staining with a phycoerythrin emission signal detector. 
The percentage of apoptotic cells in 10 000 cells was deter-
mined, after which all the experiments were performed 3 
times. The data were analyzed using WinMDI 2.8 software 
(Scripps Institute, La Jolla, CA, USA) for calculation of per-
centage of apoptotic cells per group.
in vitro invasion assays
Invasion assays were done using a modified Transwell 
chamber system as described previously (13). Cells 
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(2 × 105) were seeded on Matrigel-coated membrane in-
serts with a pore size of 8 µm (BD Bioscience, Heidelberg, 
Germany) in the presence of DMEM supplemented with 
10% FBS. The same medium of 750 µL was placed in the 
lower wells of the chamber system. Thereafter, the cells 
were irradiated and incubated for 24 hours. The cells on 
the upper side were scraped off with a rubber policeman 
and the cells that had migrated into the lower compart-
ment were fixed (4% paraformaldehyde in phosphate buff-
ered saline, PBS), stained with hematoxylin and eosin, and 
counted from 5 random high power fields at 200 magnifi-
cation in each well.
statistical analysis
Data are shown as means ± standard deviation of replicate 
samples in single experiments or replicate experiments as 
described in the figure legends. t test was used to test the 
comparisons between two groups. Multiple group com-
parisons were performed by one-way ANOVA, followed 
by the Tukey-Kramer multiple group comparisons test. All 
statistical analyses were performed using SPSS statistical 
software, version 10.0 (SPSS, Chicago, IL, USA). A value of 
P < 0.05 was considered statistically significant.
ResulTs
Basal and irradiation-induced hsP70 expression
Although in our previous studies of the radiosenistivi-
ties of ISK, KLE, and RL95-2 endometrial cancer cell lines 
showed that ISK line was relatively radioresistant (2), high 
endogenous basal expression HSP70 levels were observed 
in all cell lines (Figure 1). However, the irradiation-induced 
overexpression of HSP70 was only observed in ISK cells 
(14.31 ± 1.24 vs 5.82 ± 0.93, P = 0.014) (Figure 1).
hsP70 expression in isK cells transfected with siRna-
hsP70 and pcDna3-hsP70
We examined the HSP70 mRNA and HSP70 protein expres-
sion in ISK cells transfected with vehicle, siRNA-HSP70, and 
pcDNA3-HSP70 (Figure 2). Transfection with siRNA-HSP70 
resulted in dramatic reduction of endogenous levels of 
HSP70 compared with the vehicle control (ie, up to 95%, 
P < 0.001) and in the inhibition of irradiation-mediated 
HSP70 induction (ie, up to 90%, P < 0.001). Transfection of 
HSP70 resulted in 2.7-fold increase in ectopic expression 
of HSP70 compared with the vehicle control (P = 0.018) 
and 2.1-fold increase in irradiation-mediated HSP70 
Figure 1.
Basal and irradiation-induced expression of hsP70 mRna in isK, Rl95-2, 
and Kle cells. The level of mRna was determined by quantitative real-
time polymerase chain reaction. Bars represent the means and error bars 
standard deviations from 3 independent experiments. *P = 0.014 vs con-
trol. Closed bars – no radiation, grey bars – radiation.
Figure 2.
expression of hsP70 in isK cells transfected with siRna-hsP70 (isK/siR-
na), control siRna (isK/Control), pcDna3-hsP70 (isK/hsP70), or pcD-
na3.1 (isK/neo). (A) Quantitive real-time validation confirmed signifi-
cant differential expression of hsP70 in isK/siRna and isK/hsP70 cells vs 
control cells. Closed bars – no radiation; open bars – radiation; asterisk 
– P < 0.05 vs control; double asterisk – P < 0.01 vs control. (B) Representa-
tive Western blots demonstrating expression of hsP70 in cells transfect-
ed as shown above. 
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induction (P = 0.037). These findings were confirmed by 
western-blot analysis of HSP70 protein expression.
siRna-hsP70 radiosensitizes isK cells
Clonogenic survival assays were used to examine the abil-
ity of siRNA-HSP70 to sensitize ISK cells to the effects of 
radiation. Irradiation alone resulted in a dose-dependent 
reduction in cell survival and the effect was significantly 
enhanced in the cells transfected with siRNA-HSP70 before 
irradiation, compared with control (Figure 3A). Cell killing 
induced by 4 Gy irradiation in ISK/siRNA-HSP70 was com-
parable with that observed in ISK/control at a dose of 5.1 
Gy irradiation, corresponding to an enhancement factor of 
1.27. Furthermore, transfection of cells with small interfer-
ing RNA to silence HSP70 abolished the shoulder of radia-
tion dose-response curves, which is considered to reflect 
repair of sublethal damage (15). Cells transfected with the 
nonspecific RNA clearly retained the usual shoulder.
To investigate the effects of irradiation on the induction 
of apoptosis in ISK/control and ISK/siRNA-HSP70 cells, flow 
cytometric measurement was used to quantify the per-
centage of apoptotic cells in the total cell population. Af-
ter 24-hour irradiation, the percentage of apoptotic cells 
significantly increased in ISK/siRNA-HSP70 cells compared 
with control (6.74% vs 14.22%, P = 0.021, Figure 3B). How-
ever, there was no significant difference between the two 
groups before irradiation (3.66% vs 5.18%, P = 0.087). These 
results indicated that a decrease in HSP70 protein en-
hanced the ability of irradiation to inhibit the survival and 
improve apoptosis of ISK cells.
increased expression of hsP70 improved the survival of 
isK cells after exposure to radiation
To determine whether increased expression of HSP70 
conferred protection against irradiation, cell survival was 
Figure 3.
hsP70 enhances resistance of isK cells to ionizing radiation and silenc-
ing the gene radiosensitizes isK cells. (A) Clonogenic survival curves 
(mean±standard deviation of 5 independent experiments) for cells 
transfected with siRna-hsP70 (isK/siRna), control siRna (isK/Control), 
pcDna3-hsP70 (isK/hsP70), or pcDna3.1 (isK/neo) exposed by x-ray 
radiation. (B) Flow cytometric analysis of irradiation-induced apoptosis 
(mean±standard deviation of three independent experiments). Closed 
bars – no radiation, open bars – radiation. asterisk – P < 0.05 vs control.
Figure 4.
Cell invasiveness of isK/control, isK/siRna, isK/neo and isK/hsP70 be-
fore or after irradiation exposure. (A) Cells were on the lower surface 
of the transwell filters (magnification ×200). (B) The number of cells 
(mean±standard deviation of 3 independent experiments) that invaded 
through the filters was counted under a microscope in 5 views. Closed 
bars – no radiation, open bars – radiation. asterisk – P < 0.05 vs control; 
double asterisk – P < 0.01 vs control.
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examined in irradiated ISK/HSP70 and ISK/Neo cells. We 
found that overexpression of HSP70 increased cell survival 
in ISK/HSP70 cells. For example, after 4 Gy irradiation, ISK 
cell survival fraction was reduced to 0.32 ± 0.04 in com-
parison with untreated cells (reference value = 1), but the 
survival fraction of ISK/siRNA-HSP70 cell was increased to 
0.51 ± 0.08 (P = 0.026; Figure 3A).
After 24-hour irradiation, a significantly lower percentage 
of apoptotic cells was observed in ISK/HSP70 than mock 
transfected ISK/Neo cells (7.15% vs 4.08%, P = 0.043; Fig-
ure 3B). These results indicated that the overexpression of 
HSP70 protein inhibited apoptosis and improves the sur-
vival of ISK cells after exposure to radiation.
hsP70 promotes invasive potential in isK cells
The invasiveness of ISK cells transfected with siRNA and 
HSP70 was determined using matrigel invasion assay. ISK 
cells irradiated at doses of 4 Gy had more invasive cells 
than untreated controls, but the difference was not signifi-
cant (P = 0.083, Figure 4). Silencing HSP70 significantly in-
hibited cell invasion before and after irradiation (106 ± 19 
vs 219 ± 18 and 119 ± 16 vs 256 ± 31, P = 0.007, Figure 4A, 
4B). On the contrary, more ISK/HSP70 cells invaded through 
the filters than mock transfected ISK/Neo cells before and 
after irradiation (274 ± 21 vs 194 ± 16 before irradiation, and 
298 ± 24 vs 227 ± 19 after irradiation, respectively, P = 0.032). 
These results indicated that HSP70 promoted invasiveness 
in ISK cells and abortion of this gene may act as a means to 
inhibit cell invasion in endometrial cancer.
DisCussion
Our study demonstrated that, although all 3 tested en-
dometrial cancer cell lines had high endogenous basal 
expression HSP70 levels, the irradiation-induced overex-
pression of HSP70 was observed only in radioresistant ISK 
cells, but not in relatively radiosensitive KLE or RL95-2 cells. 
These results suggest that the effect of treatment by irra-
diation should not simply be predicted by the basal HSP70 
level in endometrial cancer. In fact, irradiation-induced 
HSP70 expression may play an important role in radiore-
sistance. HSP70 silencing caused a significant increase in 
irradiation-induced cell killing and in the percentage of ap-
optotic cells. Moreover, HSP70 silencing significantly inhib-
ited cell invasion before and after irradiation.
HSP70 is present in a variety of malignant cell types and 
its expression is induced by several stressors, such as 
hyperthermia, infection, UV radiation, as well as γ-radiation. 
HSP70 is known to rescue cells from tumor necrosis, factor-
induced caspase-independent programmed cell death, 
heat shock, serum starvation, and oxidative stress. It is as-
sociated with increased cell proliferation, inhibition of ap-
optosis, lymph node metastasis, higher clinical stage, and 
poor prognosis in endometrial cancer (16,17).
Inducible HSP70 has been suggested to have multiple 
roles in cytoprotection against irradiation-induced apopto-
sis. Brondani et al reported that the content of HSP70 was 
associated with glioblastoma cell radioresistance (9). The 
overexpression of HSP70 also enhanced radioresistance of 
mouse embryo fibroblasts and fibrosarcoma (18,19). Sev-
eral preclinical studies evaluated the antitumor potency of 
HSP70 inhibitors which inhibit tumor growth and enhance 
radiation response in vitro as well as in vivo (20-23). HSP70 
has been considered as a potential target for cancer ther-
apy in recent years (24). However, little is known about its 
role in radiosensitivity of endometrial cancer.
Given that a number of potential mechanisms explain the 
relation between HSP70 and radioresistance, specific over-
expression and suppression of the HSP70 gene could help 
elucidate the precise role of HSP70 in cancer radiothera-
py. Our results identified that cells depleted of HSP70 dis-
played strikingly different radiosensitivity. Cells transfected 
with siRNA showed enhanced radiosensitivity compared 
with cells transfected with vehicle or HSP70. We also ob-
served that increased constitutive expression of HSP70 in 
ISK cells was critical for radioresistance, because specific 
cells transfected with HSP70 led to a lower apoptosis and 
greater clonogenicity.
Malignant progression of cancer depends not only on rap-
id proliferation of tumor cells but also on other biological 
behaviors including motility, invasiveness, and metastatic 
potential. The metastasis of cancer cells is one of the major 
factors deciding the cancer outcome. However, changes 
in motility or invasive potential after irradiation have been 
poorly understood. Radiation-induced enhancement in 
invasiveness was observed in glioblastoma, hepatocellu-
lar, breast, and pancreatic carcinoma (25-27). The mech-
anism may be associated with overexpression of MMP-2 
and MMP-9 through the PI3K/Akt/NF-kappaB signal trans-
duction pathway or activation of epidermal growth fac-
tor receptor (EGFR). Although we did not find remarkable 
enhancement of invasiveness after irradiation-exposure 
in ISK cells, we showed that irradiation promoted invasive 
potential in ISK/HSP70 cells, whereas cell proliferation was 
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significantly suppressed. However, cells with HSP70 deple-
tion inhibited invasion after irradiation, which suggests 
that this radiation-enhanced invasiveness may be associ-
ated with an increased expression of HSP70 and abortion 
of this gene may act as a means to inhibit cell invasion in 
endometrial cancer although its mechanism still awaits in-
vestigation.
To the best of our knowledge, this study is the first report 
suggesting that in vitro radiosensitivity of endometrial 
cancer cells may not be controlled by the basal expres-
sion level of HSP70 but be at least partly dependent on 
the irradiation-induced HSP70 content. Increased consti-
tutive expression of HSP70 plays a critical role in endome-
trial cancer cells radioresistance and invasiveness, because 
specific transfection of HSP70 promotes clonogenicity and 
increases cell invasion. Furthermore, abrogation of HSP70 
induction significantly enhances apoptotic effects of irra-
diation and reduces cell invasiveness. According to our re-
sults, siRNA-HSP70 can be used as a means to increase ra-
diosensitivity and depress invasiveness in the treatment for 
endometrial cancer.
acknowledgment
This work was supported by the grant from The Shandong 
Provincial Natural Science Foundation (No. Y2006C88).
Reference
1 anderson PR. The role of radiation therapy in locally advanced 
endometrial cancer. semin Radiat oncol. 2006;16:152-7. 
Medline:16814155 doi:10.1016/j.semradonc.2006.02.003
2 Du Xl, Jiang T, Wen ZQ, li Qs, Gao R, Wang F. Differential expres-
sion profiling of gene response to ionizing radiation in two en-
dometrial cancer cell lines with distinct radiosensitivities. oncol 
Rep. 2009;21:625-34. Medline:19212620
3 Daugaard M, Rohde M, Jaattela M. The heat shock protein 70 
family: highly homologous proteins with overlapping and dis-
tinct functions. FeBs lett. 2007;581:3702-10. Medline:17544402 
doi:10.1016/j.febslet.2007.05.039
4 noonan e, Giardina C, hightower l. hsp70B’ and hsp72 form a 
complex in stressed human colon cells and each contributes to 
cytoprotection. exp Cell Res. 2008;314:2468-76. Medline:18579131 
doi:10.1016/j.yexcr.2008.05.002
5 Kalogeraki a, Giannikaki e, Tzardi M, Kafousi M, ieromonachou P, 
Dariviannaki K, et al. Correlation of heat shock protein (hsP70) ex-
pression with cell proliferation (MiB1), estrogen receptors (eR) and 
clinicopathological variables in invasive ductal breast carcinomas. J 
exp Clin Cancer Res. 2007;26:367-8. Medline:17987797
6 Ciocca DR, Calderwood sK. heat shock proteins in cancer: diagnos-
tic, prognostic, predictive, and treatment implications. Cell stress 
Chaperones. 2005;10:86-103. Medline:16038406 doi:10.1379/CsC-
99r.1
7 Bausero Ma, Page DT, osinaga e, asea a. surface expression of 
hsp25 and hsp72 differentially regulates tumor growth and 
metastasis. Tumour Biol. 2004;25:243-51. Medline:15627887 
doi:10.1159/000081387
8 Wataba K, saito T, Fukunaka K, ashihara K, nishimura M, Kudo 
R. over-expression of heat shock proteins in carcinogenic en-
dometrium. int J Cancer. 2001;91:448-56. Medline:11251965 
doi:10.1002/1097-0215(200002)9999:9999<::aiD-
iJC1077>3.0.Co;2-F
9 Gehrmann M, Marienhagen J, eichholtz-Wirth h, Fritz e, ellwart J, 
Jaattela M, et al. Dual function of membrane-bound heat shock 
protein 70 (hsp70), Bag-4, and hsp40: protection against radia-
tion-induced effects and target structure for natural killer cells. 
Cell Death Differ. 2005;12:38-51. Medline:15592361 doi:10.1038/
sj.cdd.4401510
10 Brondani Da Rocha a, Regner a, Grivicich i, Pretto schunemann D, 
Diel C, Kovaleski G, et al. Radioresistance is associated to increased 
hsp70 content in human glioblastoma cell lines. int J oncol. 
2004;25:777-85. Medline:15289883
11 Bases R. Clonogenicity of human leukemic cells protected from 
cell-lethal agents by heat shock protein 70. Cell stress Chaperones. 
2005;10:37-45. Medline:15832946 doi:10.1379/CsC-58R.1
12 Zhao ZG, Ma QZ, Xu CX. abrogation of heat-shock protein (hsP)70 
expression induced cell growth inhibition and apoptosis in human 
androgen-independent prostate cancer cell line PC-3m. asian J an-
drol. 2004;6:319-24. Medline:15546023
13 lee KJ, Kim YM, Kim DY, Jeoung D, han K, lee sT, et al. Release 
of heat shock protein 70 (hsp70) and the effects of extracellular 
hsp70 on matric metalloproteinase-9 expression in human mono-
cytic u937 cells. exp Mol Med. 2006;38:364-74. Medline:16953115
14 livak KJ, schmittgen TD. analysis of relative gene expression data 
using real-time quantitative PCR and the 2(-Delta Delta C(T)) 
method. Methods. 2001;25:402-8. Medline:11846609 doi:10.1006/
meth.2001.1262
15 vanankeren sC, Murray D, stafford PM, Meyn Re. Cell survival and 
recovery processes in Chinese hamster aa8 cells and in two radio-
sensitive clones. Radiat Res. 1988;115:223-37. Medline:3406365 
doi:10.2307/3577160
16 Bai XX, Chen YQ, Xin XY, Wang WD. expression and significance 
of heat shock protein 70, 90 in endometrial carcinomas [in 
Chinese]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003;19:38-40. 
Medline:15132902
17 Wataba K, saito T, Fukunaka K, ashihara K, nishimura M, Kudo 
R. over-expression of heat shock proteins in carcinogenic en-
dometrium. int J Cancer. 2001;91:448-56. Medline:11251965 
doi:10.1002/1097-0215(200002)9999:9999<::aiD-
iJC1077>3.0.Co;2-F
18 Park sh, lee sJ, Chung hY, Kim Th, Cho CK, Yoo sY, et al. inducible 
heat-shock protein 70 is involved in the radioadaptive response. 
Radiat Res. 2000;153:318-26. Medline:10669554 doi:10.1667/0033-
7587(2000)153[0318:ihsPii]2.0.Co;2
19 Kabakov ae, Malyutina YV, latchman Ds. hsf1-mediated stress 
response can transiently enhance cellular radioresistance. 
Radiat Res. 2006;165:410-23. Medline:16579653 doi:10.1667/
RR3514.1
CLINICAL SCIENCE150 Croat Med J. 2009; 50: 143-50
www.cmj.hr
20 ishibashi J, Yamashita K, ishikawa T, hosokawa h, sumida K, nagaya-
ma M, et al. The effects inhibiting the proliferation of cancer cells 
by far-infrared radiation (FiR) are controlled by the basal expression 
level of heat shock protein (hsP) 70a. Med oncol. 2008;25:229-37. 
Medline:17968683 doi:10.1007/s12032-007-9020-4
21 Calini V, urani C, Camatini M. overexpression of hsP70 is induced 
by ionizing radiation in C3h 10T1/2 cells and protects from 
Dna damage. Toxicol in Vitro. 2003;17:561-6. Medline:14599445 
doi:10.1016/s0887-2333(03)00116-4
22 hunt CR, Dix DJ, sharma GG, Pandita RK, Gupta a, Funk M, et al. 
Genomic instability and enhanced radiosensitivity in hsp70.1- 
and hsp70.3-deficient mice. Mol Cell Biol. 2004;24:899-911. 
Medline:14701760 doi:10.1128/MCB.24.2.899-911.2004
23 Kabakov ae, Malyutina YV, latchman Ds. hsf1-mediated stress re-
sponse can transiently enhance cellular radioresistance. Radiat Res. 
2006;165:410-23. Medline:16579653 doi:10.1667/RR3514.1
24 havik B, Bramham CR. additive viability-loss following hsp70/
hsc70 double interference and hsp90 inhibition in two breast can-
cer cell lines. oncol Rep. 2007;17:1501-10. Medline:17487411
25 Paquette B, Baptiste C, Therriault h, arguin G, Plouffe B, lemay 
R. in vitro irradiation of basement membrane enhances the in-
vasiveness of breast cancer cells. Br J Cancer. 2007;97:1505-12. 
Medline:17987037 doi:10.1038/sj.bjc.6604072
26 Cheng JC, Chou Ch, Kuo Ml, hsieh CY. Radiation-enhanced hepa-
tocellular carcinoma cell invasion with MMP-9 expression through 
Pi3K/akt/nF-kappaB signal transduction pathway. oncogene. 
2006;25:7009-18. Medline:16732316 doi:10.1038/sj.onc.1209706
27 Qian lW, Mizumoto K, urashima T, nagai e, Maehara n, sato n, 
et al. Radiation-induced increase in invasive potential of human 
pancreatic cancer cells and its blockade by a matrix metallo-
proteinase inhibitor, CGs27023. Clin Cancer Res. 2002;8:1223-7. 
Medline:11948136
